Regeneron Pharmaceuticals Inc. buy TD Cowen
Summary
This prediction ended on 07.12.24 with a price of €742.40. With a performance of -4.94%, the BUY prediction by TD_Cowen finished with a loss. TD_Cowen has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. TD_Cowen has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.533% | 0.533% | 21.874% |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % |
Comments by TD_Cowen for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.
Current prediction by TD_Cowen for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
23.04.26
23.04.27
24.04.26
Stopped prediction by TD_Cowen for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
23.07.24
23.07.25
24.07.25
Regeneron Pharmaceuticals Inc.
24.04.24
24.04.25
25.04.25

